(NASDAQ: DRIO) Dariohealth's forecast annual revenue growth rate of 35.02% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.13%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Dariohealth's revenue in 2025 is $28,034,000.On average, 2 Wall Street analysts forecast DRIO's revenue for 2025 to be $1,416,929,430, with the lowest DRIO revenue forecast at $1,258,272,009, and the highest DRIO revenue forecast at $1,575,586,850.
In 2026, DRIO is forecast to generate $2,246,035,314 in revenue, with the lowest revenue forecast at $1,587,013,701 and the highest revenue forecast at $2,905,056,926.